Recombinant adeno-asociated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: Comparison of rubrospinal and corticospinal tracts in the rat

Human Gene Therapy

Volumn 19, Issue 1, 2008, Pages 71-81

  Foust, Kevin D ^a,b   Flotte, Terence R ^c   Reier, Paul J ^a   Mandel, Ronald J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; RECOMBINANT PROTEIN; SOMATOMEDIN C; VASCULOTROPIN; VIRUS VECTOR; RECOMBINANT DNA;

ADENO ASSOCIATED VIRUS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; GLIA CELL; GRAY MATTER; IMMUNOHISTOCHEMISTRY; MOTOR CORTEX; NONHUMAN; RAT; RUBROSPINAL TRACT; SPINAL CORD; VIRUS RECOMBINANT; ANIMAL; COMPARATIVE STUDY; GENE VECTOR; GENETICS; MALE; METABOLISM; METHODOLOGY; PYRAMIDAL TRACT; SPRAGUE DAWLEY RAT;

ADENO-ASSOCIATED VIRUS; RATTUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DEPENDOVIRUS; DNA, RECOMBINANT; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; MALE; PYRAMIDAL TRACTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 38649088870     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.104     Document Type: Article

References (30)

1. ACSADI, G., ANGUELOV, R.A., YANG, H., TOTH, G., THOMAS, R., JANI, A., WANG, Y., IANAKOVA, E., MOHAMMAD, S., LEWIS, R.A., and SHY, M.E. (2002). Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum. Gene Ther. 13, 1047-1059.
2. AZZOUZ, M., RALPH, G.S., STORKEBAUM, E., WALMSLEY, L.E., MITROPHANOUS, K.A., KINGSMAN, S.M., CARMELIET, P., and MAZARAKIS, N.D. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413-417.
3. BLESCH, A., and TUSZYNSKI, M.H. (2001). GDNF gene delivery to injured adult CNS motor neurons promotes axonal growth, expression of the trophic neuropeptide CGRP, and cellular protection. J. Comp. Neurol. 436, 399-410.
4. BOILLEE, S., VANDE VELDE, C., and CLEVELAND, D.W. (2006). ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59.
5. BORASIO, G.D., ROBBERECHT, W., LEIGH, P.N., EMILE, J., GUILOFF, R.J., JERUSALEM, F., SILANI, V., VOS, P.E., WOKKE, J.H., and DOBBINS, T. (1998). A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology 51, 583-586.
6. BRUIJN, L.I., MILLER, T.M., and CLEVELAND, D.W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723-749.
7. CHAMBERLIN, N.L., DU, B., DE LACALLE, S., and SAPER, C.B. (1998). Recombinant adeno-associated virus vector: Use for transgene expression and anterograde tract tracing in the CNS. Brain Res. 793, 169-175.
8. ENTERZARI-TAHER, M., EISEN, A., STEWART, H., and NAKAJIMA, M. (1997). Abnormalities of cortical inhibitory neurons in amyotrophic lateral sclerosis. Muscle Nerve 20, 65-71.
9. GEORGIEVSKA, B., KIRIK, D., and BJORKLUND, A. (2002). Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177, 461-474.
10. GUILLOT, S., AZZOUZ, M., DEGLON, N., ZURN, A., and AEBISCHER, P. (2004). Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1G93A transgenic mice. Neurobiol. Dis. 16, 139-149.
11. JOOSTEN, E.A. (1997). Corticospinal tract regrowth. Prog. Neurobiol. 53, 1-25.
12. KASPAR, B.K., LLADO, J., SHERKAT, N., ROTHSTEIN, J.D., and GAGE, F.H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839-842.
13. KIRIK, D., ROSENBLAD, C., BJORKLUND, A., and MANDEL, R.J. (2000). Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci. 20, 4686-4700.
14. KOBBERT, C., APPS, R., BECHMANN, I., LANCIEGO, J.L., MEY, J., and THANOS, S. (2000). Current concepts in neuroanatomical tracing. Prog. Neurobiol. 62, 327-351.
15. KUCHLER, M., FOUAD, K., WEINMANN, O., SCHWAB, M.E., and RAINETEAU, O. (2002). Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J. Comp. Neurol. 448, 349-359.
16. LAI, E.C., FELICE, K.J., FESTOFF, B.W., GAWEL, M.J., GELINAS, D.F., KRATZ, R., MURPHY, M.F., NATTER, H.M., NORRIS, F.H., and RUDNICKI, S.A. (1997). Effect of recombinant human insulin-like growth factor-I on progression of ALS: A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology 49, 1621-1630.
17. LILLICRAP, D., VANDENDRIESSCHE, T., and HIGH, K. (2006). Cellular and genetic therapies for haemophilia. Haemophilia 12(Suppl. 3), 36-41.
18. LU, Y.Y., WANG, L.J., MURAMATSU, S., IKEGUCHI, K., FUJIMOTO, K., OKADA, T., MIZUKAMI, H., MATSUSHITA, T., HANAZONO, Y., KUME, A., NAGATSU, T., OZAWA, K., and NAKANO, I. (2003). Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport. Neurosci. Res. 45, 33-40.
19. MANDEL, R.J., MANFREDSSON, F.P., FOUST, K.D., RISING, A., REIMSNIDER, S., NASH, K., and BURGER, C. (2006). Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol. Ther. 13, 463-483.
20. MILLER, T.M., KIM, S.H., YAMANAKA, K., HESTER, M., UMAPATHI, P., ARNSON, H., RIZO, L., MENDELL, J.R., GAGE, F.H., CLEVELAND, D.W., and KASPAR, B.K. (2006). Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 103, 19546-19551.
21. NARAI, H., NAGANO, I., ILIEVA, H., SHIOTE, M., NAGATA, T., HAYASHI, T., SHOJI, M., and ABE, K. (2005). Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. J. Neurosci. Res. 82, 452-457.
22. NIWA, H., YAMAMURA, K., and MIYAZAKI, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
23. STORKEBAUM, E., LAMBRECHTS, D., DEWERCHIN, M., MORENO-MURCIANO, M.P., APPELMANS, S., OH, H., VAN DAMME, P., RUTTEN, B., MAN, W.Y., DE MOL, M., WYNS, S., MANKA, D., VERMEULEN, K., VAN DEN BOSCH, L., MERTENS, N., SCHMITZ, C., ROBBERECHT, W., CONWAY, E.M., COLLEN, D., MOONS, L., and CARMELIET, P. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8, 85-92.
24. VON BARTHELD, C.S. (2004). Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens. J. Neurobiol. 58, 295-314.
25. XU, Z.L., MIZUGUCHI, H., ISHII-WATABE, A., UCHIDA, E., MAYUMI, T., and HAYAKAWA, T. (2002). Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. J. Control. Release 81, 155-163.
26. YANG, H.W., and LEMON, R.N. (2003). An electron microscopic examination of the corticospinal projection to the cervical spinal cord in the rat: Lack of evidence for cortico-motoneuronal synapses. Exp. Brain Res. 149, 458-469.
27. ZAISS, A.K., and MURUVE, D.A. (2005). Immune responses to adeno-associated virus vectors. Curr. Gene Ther. 5, 323-331.
28. ZOLOTUKHIN, S., BYRNE, B.J., MASON, E., ZOLOTUKHIN, I., POTTER, M., CHESNUT, K., SUMMERFORD, C., SAMULSKI, R.J., and MUZYCZKA, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985.
29. ZOLOTUKHIN, S., POTTER, M., ZOLOTUKHIN, I., SAKAI, Y., LOILER, S., FRAITES, T.J., JR., CHIODO, V.A., PHILLIPSBERG, T., MUZYCZKA, N., HAUSWIRTH, W.W., FLOTTE, T.R., BYRNE, B.J., and SNYDER, R.O. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28, 158-167.
30. ZUFFEREY, R., DONELLO, J.E., TRONO, D., and HOPE, T.J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886-2892.